Literature DB >> 15135720

Famotidine and long QT syndrome.

Ken W Lee1, Steven R Kayser, Richard H Hongo, Zian H Tseng, Melvin M Scheinman.   

Abstract

Numerous drugs have been implicated in causing a prolonged QT interval and Torsades de pointes. However, the association of famotidine and acquired long QT syndrome has rarely been reported. We report 2 cases of famotidine-associated acquired long QT syndrome.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15135720     DOI: 10.1016/j.amjcard.2004.02.025

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

Review 1.  Reckless administration of QT interval-prolonging agents in elderly patients with drug-induced torsade de pointes.

Authors:  Galia Jackobson; Narin Nard Carmel; Dor Lotan; Anjelika Kremer; Dan Justo
Journal:  Z Gerontol Geriatr       Date:  2016-11-22       Impact factor: 1.281

Review 2.  Antacid Therapy in Coronary Artery Disease and Heart Failure: Proton Pump Inhibitors vs. H2 Receptor Blockers.

Authors:  Muzamil Khawaja; Janki Thakker; Riyad Kherallah; Masafumi Kitakaze; Hani Jneid; Dominick J Angiolillo; Yochai Birnbaum
Journal:  Cardiovasc Drugs Ther       Date:  2022-06-18       Impact factor: 3.727

Review 3.  Sensitive and reliable proarrhythmia in vivo animal models for predicting drug-induced torsades de pointes in patients with remodelled hearts.

Authors:  A Sugiyama
Journal:  Br J Pharmacol       Date:  2008-06-16       Impact factor: 8.739

4.  Effects of palonosetron on prolongation of corrected QT intervals may be less than reliable.

Authors:  Jeounghyuk Lee; Junyong In
Journal:  Korean J Anesthesiol       Date:  2014-04

5.  Association Between Proton Pump Inhibitors and Asthma: A Population-Based Cohort Study.

Authors:  Yao-Tung Wang; Ming-Chang Tsai; Yu-Hsun Wang; James Cheng-Chung Wei
Journal:  Front Pharmacol       Date:  2020-05-08       Impact factor: 5.810

6.  Sustainable Drug Delivery of Famotidine Using Chitosan-Functionalized Graphene Oxide as Nanocarrier.

Authors:  Chetan Ramesh Mahajan; Lalit B Joshi; Umakant Varma; Jitendra B Naik; Vijay Raman Chaudhari; Satyendra Mishra
Journal:  Glob Chall       Date:  2019-08-14

Review 7.  A Bitter Taste in Your Heart.

Authors:  Conor J Bloxham; Simon R Foster; Walter G Thomas
Journal:  Front Physiol       Date:  2020-05-08       Impact factor: 4.566

8.  Prediction of potential drug interactions between repurposed COVID-19 and antitubercular drugs: an integrational approach of drug information software and computational techniques data.

Authors:  Levin Thomas; Sumit Raosaheb Birangal; Rajdeep Ray; Sonal Sekhar Miraj; Murali Munisamy; Muralidhar Varma; Chidananda Sanju S V; Mithu Banerjee; Gautham G Shenoy; Mahadev Rao
Journal:  Ther Adv Drug Saf       Date:  2021-08-26

9.  Severe QT interval prolongation associated with moxifloxacin: a case report.

Authors:  Tetsuro Koide; Masato Shiba; Katsuhiro Tanaka; Masatoshi Muramatsu; Satoshi Ishida; Yoshihiro Kondo; Keiko Watanabe
Journal:  Cases J       Date:  2008-12-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.